leadersmarket grants and awardsnewsimage gallerycontact us welcome to immune therapy holdings ith is a biotech company located at karolinska institutet and the karolinska university hospital dedicated to innovating the next generation of personalized therapeutics and diagnostics for patients with immune related diseases . the company s research & development is focused on its award winning tailored leukapheresis tla immunotherapy for immune mediated inflammatory diseases which has been developed with the support of the european union swedish research council and swedish governmental agency for innovation systems . news tla highlighted by the swedish institute as an innovation success story tla was showcased by the swedish institute in its innovative sweden exhibition which highlights the best swedish innovations worldwide . tla ... ith enter licensing partnership with kalbe farma ith personalized cellular therapies has signed a licensing and r & d partnership agreement with kalbe farma to conduct clinical development of ... ola winqvist awarded with the 2013 athena prize professor ola winqvist ith co founder and cso was awarded the 2013 athena prize for clinical research and development of the ... about ithboard memberstailored leukapheresiscompetitive profile clinical results key opinion leadersmarket grants and awardsnewsimage gallerycontact us immune therapy holdings ab